MEDai, Inc., an Elsevier company, was incorporated in 1992 and founded on the belief that sophisticated forecasting technology and data mining can be used by the healthcare industry to achieve improved quality healthcare outcomes. 

A recognized leader in the field of predictive analytics, data mining, and clinical outcomes analysis, MEDai’s solution suites provide payers and providers with the business intelligence necessary to deliver quality care to their populations, enhance chronic care management, and improve operation efficiencies.

MEDai wraps its technology around a patient centric database allowing for robust analysis and reporting. 

Our solutions help organizations like Commercial Health Plans, Medicare Plans/Sponsors, Medicaid Plans, Government and State Agencies, Health Information Exchange Collaborative, and Hospitals leverage:

· Real-time evidence-based medicine guideline compliance monitoring
· Accurate identification and stratification of high-risk/high-cost patients
· Identification of patients at risk for readmission and hospital acquired infections
· Physician and facility profiling
· Identification of population-risk drivers and potential mitigation strategies
· Actuarial and underwriting support
· Retrospective outcomes analysis

Today, MEDai is a key part of Elsevier Clinical Decision Support, a suite of clinical decision support solutions that meet the diverse needs of physicians, nurses, pharmacists and other health professionals working in a variety of clinical settings. 

Elsevier Clinical Decision Support delivers accurate, evidence-based, actionable information whenever and wherever needed within the healthcare workflow. From concise answers to in-depth information, from interactive task guidance to real-time data analysis, Elsevier provides a spectrum of knowledge for advancing health care. To learn more about our other solutions, please visit: www.clinicaldecisionsupport.com.